I refer the member to the answer to question S6W-39850 on 5 September 2025. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.

I refer the member to the answer to question S6W-39850 on 5 September 2025. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.

Based on current planning, in early 2026, Scotland will become the first country in the UK to begin an in service evaluation (ISE) of Spinal Muscular Atrophy (SMA) screening. Under the plans, all babies in Scotland will be offered screening for the condition for at least the next two years.

The Scottish Government recognises that SMA can be devastating for babies and families, and supports any intervention that can be shown to improve the quality of life for those affected.

While there is evidence around the benefits of SMA screening, the UK National Screening Committee (UK NSC) requires further supporting evidence before it can recommend it as a long term part of the newborn screening programme.

This ISE will allow the NHS to potentially find and treat babies with SMA earlier than they otherwise might have, and will generate valuable data to inform the UK NSC’s final recommendation on SMA screening.

The evidence generated by the Scottish ISE will be submitted to the National Institute for Health and Care Research (NIHR), which will analyse it alongside data from the planned SMA ISE in England.

The Scottish Government’s decision-making throughout the COVID-19 vaccination programme has been guided by the expert clinical advice of the Joint Committee on Vaccination and Immunisation (JCVI).

In its statement of 8 April 2024 the JCVI stated it no longer advised an offer of COVID-19 vaccination for unpaid carers and household contacts of people with immunosuppression. As a result, unpaid carers and household contacts of people with immunosuppression were removed from the programme as of winter 2024-25. This position is consistent across all UK nations, and remains unchanged for winter 2025-26.

The reasons the JCVI no longer advised the inclusion of these groups are:

• that the indirect benefits of vaccination (vaccinating an individual in order to reduce the risk of severe disease in other people) became less evident compared with previous years due to high levels of population immunity;
• the fact that vaccines provide moderate protection against severe COVID-19 for a few months;
• protection against mild symptomatic infection is much more limited in terms of peak protection and duration of protection and that with the evidence available, protection against transmission is extremely limited.

In its statement of 14 November 2024, the JCVI once more updated its advice on eligibility for COVID-19 vaccination and for winter 2025-26 the following groups remain eligible:

• Residents in care homes for older adults
• All adults aged 75 years and over
• Individuals aged 6 months and over who are immunosuppressed (as defined in the 'immunosuppression' sections of tables 3 and 4 in the COVID-19 chapter of the Green Book).

The statement advised that the COVID-19 vaccination programme should now move to JCVI's standard cost effectiveness assessment, as per other routine vaccination programmes.

Furthermore, over the last four years, population immunity to COVID-19 has been increasing due to a combination of naturally acquired immunity following recovery from infection and vaccine-derived immunity. COVID-19 is now a relatively mild disease for most people, though it can still be unpleasant, with rates of hospitalisation and death from COVID-19 having reduced significantly since it first emerged. This has led to a more refined approach to the targeting of the COVID-19 vaccination programme, with a focus on individuals where there is good evidence of a high risk of hospitalisation and/or mortality.

The Scottish Government encourages those eligible to take up the offer of COVID-19 vaccination.

The Scottish Government is committed to implementing all relevant elements of the 2023 Act. Section 8 of the Bail and Release From Custody (Scotland) Act 2023 will be implemented as soon as is practicable.

The sections of the Act are being commenced at different times, with the timeline being influenced by multiple factors, including engagement with stakeholders around resource and readiness. Delivery of implementation work has been impacted by the need for collective work to safely manage the complex and high prison population in Scotland.

I refer the member to the answer to question S6W-39898 on 5 September 2025. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.

I can confirm that the next phase in Scotland’s programme to decarbonise the railway network will involve the electrification of sections on the Fife and Borders railways. Works are already underway, with significant progress being made on the electrification of the line between Haymarket and Dalmeny. This forms part of the Scottish Government’s sustained investment in Scotland’s rail infrastructure and represents the initial phase of enabling works for the future electrification of the Fife Circle services.

The Scottish Government’s ongoing commitment to electrification supports the deployment of electric and battery-electric trains. I can further confirm that ScotRail has been authorised to initiate a procurement exercise for a new electric Suburban Fleet. This procurement will facilitate the replacement of trains currently operating on the Borders Railway and in Fife, as well as replace some of Glasgow’s Suburban trains. ScotRail expects to issue a contract notice for the Suburban Fleets in Autumn 2025.

This latest Scottish Government investment will be in excess of £342 million and demonstrates our continuing commitment to making Scotland’s railway even greener, with greater capacity and reliability.

The Scottish Government recognises and values the crucial role of Allied Health Professionals (AHPs) in delivering preventative care, early intervention, and rehabilitation across Scotland. To support AHPs in balancing the demands of system pressures with service delivery, the Government invests in workforce development, provides access to professional guidance and resources, and promotes collaborative, multidisciplinary working. AHPs are also supported in maintaining their own wellbeing to sustain high-quality care.

Please find the details requested as follows:

The Scottish Government is clear that patients should not pay for any part of their NHS treatment, and NHS patients are not permitted to use purchased donor eggs for NHS treatment. However, NHS treatment should not be withdrawn from patients who purchase their own donor eggs for use in future private treatment. If a patient is unhappy with the care they have received, they should contact their NHS Board who have responsibility for delivering services.

As part of our strategic approach to healthcare science, the Scottish Government is actively undertaking work to ensure healthcare science professions, including audiology, are included as part of wider work on reform and renewal of NHS Scotland.

This sits hand in hand with activity which will enable us to be able to map our scientific workforce in NHS Scotland more accurately, strengthening capacity, training and recruitment pipelines for audiologists, and supporting better workforce planning for the future.